Effect of Vitamin D3 Supplementation on Glycated Hemoglobin (HbA1c), Fructosamine, Serum Lipids, and Body Mass Index: a Randomized, Double-blinded, Placebo-controlled Trial Among Healthy Immigrants Living in Norway
Overview
Affiliations
Objective: Despite the suggested role of vitamin D in the prevention of diabetes and cardiovascular disease or its risk factors, the evidence is not consistent and there is a paucity of randomized controlled trials in this field. We aimed to investigate the effect of 16-week daily vitamin D3 supplementation on glycated hemoglobin (HbA1c), fructosamine, body mass index (BMI), and serum lipids.
Design: Double-blind, randomized, placebo-controlled trial.
Setting: Immigrant community centers in Oslo, Norway.
Participants: 251 healthy adults aged 18-50 years with a non-Western immigrant background. All participants performed the baseline test and 215 (86%) returned to the follow-up test.
Intervention: 16 weeks of daily oral supplementation with either 10 μg vitamin D3, 25 μg vitamin D3, or placebo.
Main Outcome Measures: Difference in absolute change during the 16-week intervention between the intervention groups combined (10 or 25 μg of vitamin D3/day) and placebo, in HbA1c, fructosamine, serum lipids (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), and BMI.
Results: A total of 215 (86%) participants completed the study. Serum 25-hydroxyvitamin D increased from 29 nmol/L at baseline to 49 nmol/L after intervention, with little change in the placebo group. However, there was no difference in change of HbA1c between those receiving vitamin D3 compared with placebo (mean difference: 0.01% (95% CI -0.04 to 0.06, p=0.7)). Neither did the vitamin D3 supplementation have any effect on the other end points: fructosamine, serum lipids, and BMI.
Conclusions: 16-week vitamin D3 supplementation to healthy immigrants from South Asia, the Middle East, or Africa and now living in Norway with low vitamin D status did not improve HbA1c, fructosamine, lipid profiles, or BMI. An updated meta-analysis of similar published trials showed that our results were generally consistent with those of other studies.
Trial Registration Number: NCT01263288.
Vitamin D level regulates serum lipids discrepantly in adults with and without dyslipidemia.
Cheng Y, Lee T, Chien Y, Lee T, Chen Y Endocr Connect. 2023; 12(9).
PMID: 37410091 PMC: 10448594. DOI: 10.1530/EC-23-0013.
Migration health research in Norway: a scoping review.
Laue J, Diaz E, Eriksen L, Risor T Scand J Public Health. 2021; 51(3):381-390.
PMID: 34609260 PMC: 10251465. DOI: 10.1177/14034948211032494.
Stoica R, Guja C, Pantea-Stoian A, Staden R, Popa-Tudor I, Stefan S Medicina (Kaunas). 2021; 57(1).
PMID: 33396784 PMC: 7824327. DOI: 10.3390/medicina57010025.
Randhawa F, Mustafa S, Khan D, Hamid S Pak J Med Sci. 2017; 33(4):881-885.
PMID: 29067058 PMC: 5648957. DOI: 10.12669/pjms.334.12288.
Guo J, Cockcroft J, Elwood P, Pickering J, Lovegrove J, Givens D Public Health Nutr. 2017; 20(15):2744-2753.
PMID: 28803595 PMC: 10261356. DOI: 10.1017/S1368980017001732.